Normal view MARC view ISBD view

Recombinant human activated protein C, drotrecogin alfa (activated): a novel therapy for severe sepsis.

Kanji, S

Recombinant human activated protein C, drotrecogin alfa (activated): a novel therapy for severe sepsis. [electronic resource] - Pharmacotherapy Nov 2001 - 1389-402 p. digital

Publication Type: Journal Article; Review

ISSN: 0277-0008

Standard No.: 10.1592/phco.21.17.1389.34417 doi

Subjects--Topical Terms:
Animals
Anti-Inflammatory Agents, Non-Steroidal--adverse effects
Fibrinolytic Agents--adverse effects
Humans
Protein C--adverse effects
Recombinant Proteins--adverse effects
Sepsis--drug therapy

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)